Länder Analysen: Schweiz
| 21.01.20 | UBS Underweight | Barclays Capital | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | Novartis Underweight | Barclays Capital | |
| 15.01.20 | Nestlé Underperform | Credit Suisse Group | |
| 14.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 13.01.20 | Givaudan Underperform | Bernstein Research | |
| 10.01.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 10.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 08.01.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 06.01.20 | Givaudan Underweight | Morgan Stanley | |
| 06.01.20 | Novartis verkaufen | Morgan Stanley | |
| 06.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 16.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.12.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.12.19 | Givaudan Underperform | Credit Suisse Group | |
| 06.12.19 | Swiss Re Sell | UBS AG | |
| 06.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.11.19 | UBS Underweight | Barclays Capital | |
| 27.11.19 | Roche Reduce | HSBC | |
| 26.11.19 | Swiss Re Sell | UBS AG | |
| 18.11.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 04.11.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.11.19 | Swiss Re Sell | UBS AG | |
| 31.10.19 | Swiss Re Sell | UBS AG | |
| 30.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 25.10.19 | Novartis Underweight | Barclays Capital | |
| 25.10.19 | Glencore Underweight | JP Morgan Chase & Co. | |
| 24.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | Novartis Underweight | Barclays Capital | |
| 23.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 21.10.19 | Novartis Underweight | Morgan Stanley | |
| 18.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.10.19 | Nestlé Underperform | RBC Capital Markets | |
| 17.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 15.10.19 | Nestlé Underperform | Credit Suisse Group | |
| 14.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 14.10.19 | UBS Underweight | Barclays Capital | |
| 11.10.19 | Givaudan Underperform | Bernstein Research | |
| 10.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 08.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |